Lateral Flow Immunoassay for Simultaneous Hemoglobin Variant Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing sickle cell and hemoglobin C diseases are complex, costly, and often unavailable in low-resource settings, lacking sensitive and specific point-of-care solutions for early detection, especially in newborns, leading to delayed diagnosis and poor prognosis.
Innovation Solution
Development of a lateral flow immunoassay system using specific antibodies immobilized on a test strip, capable of simultaneously detecting and differentiating hemoglobin A, S, and C, with conjugated detector antibodies for qualitative and quantitative analysis, allowing for rapid and cost-effective screening.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional tests (zone electrophoresis, isoelectric focusing, HPLC, DNA analysis) are used for hemoglobinopathy detection, then measurement precision and reliability are improved, but device complexity and cost increase significantly
Solution Approach 1:
The test strip is segmented into multiple distinct test lines, each targeting a specific hemoglobin variant (HbS, HbC, HbA). This segmentation allows simultaneous detection of multiple analytes in a single assay, maintaining high measurement precision while simplifying the overall testing process compared to sequential traditional methods
Solution Approach 2:
The lateral flow immunoassay platform serves multiple functions: it detects different hemoglobin variants, provides qualitative and quantitative analysis, and can be performed with minimal sample preparation. The same basic assay architecture handles multiple diagnostic needs, reducing device complexity while maintaining comprehensive detection capabilities
2Measurement precision
If traditional diagnostic methods are employed, then measurement precision is improved, but ease of operation and accessibility deteriorate
Solution Approach 1:
The immunoassay system performs automated sample processing through capillary action along the test strip. The conjugated detector antibodies automatically bind to captured hemoglobin variants and generate visible signals without requiring manual intervention for each step, enabling non-specialist operators to achieve accurate results
Solution Approach 2:
The assay replaces complex mechanical and computational systems (electrophoresis equipment, HPLC instruments, DNA sequencers) with a simple lateral flow format that generates results through passive capillary flow and optical detection, dramatically improving ease of operation while maintaining detection precision
3Reliability
If conventional testing approaches are used, then reliability is improved, but loss of time and productivity decrease
Solution Approach 1:
The capture antibodies are pre-immobilized on the test strip in specific zones, and detector antibodies are pre-conjugated with detectable moieties before use. This preliminary preparation eliminates time-consuming setup steps during actual testing, allowing rapid reliable diagnosis while maintaining assay robustness
Solution Approach 2:
The lateral flow format enables continuous movement of sample through the assay zones without interruption. Sample flows continuously from the application area through capture zones to detection zones, maintaining constant diagnostic action throughout the testing period and reducing total analysis time while preserving result reliability
4Adaptability or versatility
If comprehensive hemoglobin variant detection is implemented, then adaptability is improved, but device complexity increases
Solution Approach 1:
The test strip is divided into multiple independent test lines, each equipped with capture antibodies specific to different hemoglobin variants (HbS, HbC, HbA). This spatial segmentation allows the detection of multiple analytes simultaneously through parallel reactions, expanding adaptability without proportionally increasing overall device complexity
Solution Approach 2:
The lateral flow immunoassay platform serves multiple diagnostic functions within a single device architecture. The same basic structure with modified capture antibodies can detect various hemoglobinopathies, making the system highly adaptable to different diagnostic needs while maintaining operational simplicity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system provides high specificity and sensitivity for identifying hemoglobinopathies, even in the presence of elevated fetal hemoglobin, enabling early detection and differentiation of various forms of sickle cell and hemoglobin C diseases, suitable for point-of-care use in resource-limited settings.
Implementation Method 1
a capture antibody having a binding affinity to human hemoglobin A (HbA), human sickle cell hemoglobin (HbS), or human hemoglobin C (HbC)... a conjugated detector antibody, wherein the detector antibody has a binding affinity to hemoglobin (Hb)
Implementation Method 2
lateral flow immunoassay system using specific antibodies immobilized on a test strip... capable of simultaneously detecting and differentiating hemoglobin A, S, and C
Data Source
AI summary
Screening methods and devices for detecting and diagnosing hemoglobinopathies for sickle cell disease and related phenotypes. Lateral flow immunoassay devices for the detection of hemoglobinopathies. Methods for screening for hemoglobinopathies. Kits for the detection of a hemoglobinopathy in a sample. Immunogenic peptides for producing antibodies against hemoglobin variants.